$Pritelivir Demonstrates Superior Efficacy in People Living with HIV with Refractory HSV in Phase 3 PRIOH-1$

Author: AiCuris Anti-infective Cures AG

Posted Date:

February 25, 2026

Pritelivir Demonstrates Superior Efficacy in People Living with HIV with Refractory HSV in Phase 3 PRIOH-1

AiCuris Anti-infective Cures AG

February 25, 2026
Aicuris Presents Positive Phase 3 Data for Pritelivir in Immunocompromised Patients with Refractory Herpes Simplex Virus at TANDEM

AiCuris Anti-infective Cures AG

February 7, 2026
Aicuris Announces Pritelivir Phase 3 HSV Data to Be Presented as Late-Breaking Oral Presentation at Tandem

AiCuris Anti-infective Cures AG

January 29, 2026